---
figid: PMC7699575__ijms-21-08765-g002
figtitle: Glutathione (GSH) biosynthesis pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7699575
filename: ijms-21-08765-g002.jpg
figlink: pmc/articles/PMC7699575/figure/ijms-21-08765-f002/
number: F2
caption: 'Glutathione (GSH) biosynthesis pathway. GSH is known as one of the small-molecule
  water-soluble antioxidants, the most important of somatic cells. GSH is a linear
  tripeptide formed by three amino acids: glutamic acid, cysteine and glycine. The
  thiol group present in the amino acid cysteine is considered the active site responsible
  for the antioxidant biochemical properties of glutathione. In biological systems,
  glutathione can be found in reduced form (GSH) or in oxidized form (GSSG). The oxidized
  form is a heterodimerization of the reduced form. The GSH/GSSG ratio is used to
  estimate the redox state of biological systems []. The rate-limiting compound of
  GSH synthesis is the non-essential amino acid cysteine. Cysteine can be imported
  into cells directly or in its oxidized form, cystine, through the cystine/glutamate
  antiporter system xc−. In humans, on chromosome 4, the SLC7A11 gene (solute carrier
  family 7A11) encodes the SLCA11 antiporter, which is part of a system called system
  xc−. The structure of this protein is heterodimeric and includes two chains: a specific
  light chain, xCT (SLCA11), and a heavy chain, 4F2hc (SLC3A2), which are linked by
  a disulfide bridge. The xCT chain has 12 transmembrane domains consisting of 501
  amino acids, with the N and C terminal regions located intracellularly; it is not
  glycosylated and has a molecular mass of approximately 55 kDa. The heavy chain,
  4F2hc, is a type II glycoprotein with a single transmembrane domain, an intracellular
  NH 2 terminal and a molecular weight of approximately 85 kDa. The 4F2hc chain is
  a subunit common to amino acid transport systems, while the xCT chain is unique
  to cystine/glutamate exchange. System xc− transports amino acids, independently
  of sodium and dependent on chloride, which are specific to import cystine and export
  glutamate at the same time through the plasma membrane. Both amino acids are transported
  in anionic form. The ratio of counter transport between cystine and glutamate is
  1:1. Currently, it is known that system xc− is involved in (a) cystine uptake to
  maintain the extracellular balance of cysteine/redox cystine, (b) cysteine/cystine
  uptake for GSH synthesis and (c) non-vesicular glutamate export []. Within the cell,
  cystine is reduced to cysteine. This reduction reaction can be performed by intracellular
  GSH or by the enzyme thioredoxin reductase 1 (TRR1) []. The beginning of GSH synthesis
  is the formation of the γ-glutamylcysteine molecule, which is catalyzed by the enzyme
  glutamate cysteine ligase (GCL). GCL catalyzes the binding of glutamate and cysteine
  in the presence of adenosine triphosphate (ATP). Then, the enzyme GSH synthase (GS)
  catalyzes the formation of GSH through the link between γ-glutamylcysteine and glycine
  []. GSH reduces radicals (R•) non-enzymatically and organic hydroperoxides catalyzed
  by GSH peroxidase (GPx) and is thus converted to GSH disulfide (GSSG). GSSG is recycled
  to GSH by GSH reductase (GR), a reaction that uses reduced nicotinamide adenine
  dinucleotide phosphate (NADPH) as a cofactor []. GSH S-transferase (GST) forms GSH
  (GS-R) adducts from organic molecules (R) and GSH, which together with GSH and GSSG
  are exported from the cell by ABC transporters, mainly ABC-1 and ABC-G2 [,]. Extracellular
  GSH is metabolized by the γ-glutamyl transferase (GGT) ectoenzyme, which transfers
  the γ-glutamyl residue to different acceptor amino acids, leading to the formation
  of a dipeptide containing γ-glutamyl and the cysteine glycine dipeptide, which is
  cleaved by extracellular dipeptides to generate cysteine and glycine that can be
  taken up by cells, starting the glutathione biosynthesis cycle [].'
papertitle: Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
reftext: Cadiele Oliana Reichert, et al. Int J Mol Sci. 2020 Nov;21(22):8765.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9375385
figid_alias: PMC7699575__F2
figtype: Figure
redirect_from: /figures/PMC7699575__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7699575__ijms-21-08765-g002.html
  '@type': Dataset
  description: 'Glutathione (GSH) biosynthesis pathway. GSH is known as one of the
    small-molecule water-soluble antioxidants, the most important of somatic cells.
    GSH is a linear tripeptide formed by three amino acids: glutamic acid, cysteine
    and glycine. The thiol group present in the amino acid cysteine is considered
    the active site responsible for the antioxidant biochemical properties of glutathione.
    In biological systems, glutathione can be found in reduced form (GSH) or in oxidized
    form (GSSG). The oxidized form is a heterodimerization of the reduced form. The
    GSH/GSSG ratio is used to estimate the redox state of biological systems []. The
    rate-limiting compound of GSH synthesis is the non-essential amino acid cysteine.
    Cysteine can be imported into cells directly or in its oxidized form, cystine,
    through the cystine/glutamate antiporter system xc−. In humans, on chromosome
    4, the SLC7A11 gene (solute carrier family 7A11) encodes the SLCA11 antiporter,
    which is part of a system called system xc−. The structure of this protein is
    heterodimeric and includes two chains: a specific light chain, xCT (SLCA11), and
    a heavy chain, 4F2hc (SLC3A2), which are linked by a disulfide bridge. The xCT
    chain has 12 transmembrane domains consisting of 501 amino acids, with the N and
    C terminal regions located intracellularly; it is not glycosylated and has a molecular
    mass of approximately 55 kDa. The heavy chain, 4F2hc, is a type II glycoprotein
    with a single transmembrane domain, an intracellular NH 2 terminal and a molecular
    weight of approximately 85 kDa. The 4F2hc chain is a subunit common to amino acid
    transport systems, while the xCT chain is unique to cystine/glutamate exchange.
    System xc− transports amino acids, independently of sodium and dependent on chloride,
    which are specific to import cystine and export glutamate at the same time through
    the plasma membrane. Both amino acids are transported in anionic form. The ratio
    of counter transport between cystine and glutamate is 1:1. Currently, it is known
    that system xc− is involved in (a) cystine uptake to maintain the extracellular
    balance of cysteine/redox cystine, (b) cysteine/cystine uptake for GSH synthesis
    and (c) non-vesicular glutamate export []. Within the cell, cystine is reduced
    to cysteine. This reduction reaction can be performed by intracellular GSH or
    by the enzyme thioredoxin reductase 1 (TRR1) []. The beginning of GSH synthesis
    is the formation of the γ-glutamylcysteine molecule, which is catalyzed by the
    enzyme glutamate cysteine ligase (GCL). GCL catalyzes the binding of glutamate
    and cysteine in the presence of adenosine triphosphate (ATP). Then, the enzyme
    GSH synthase (GS) catalyzes the formation of GSH through the link between γ-glutamylcysteine
    and glycine []. GSH reduces radicals (R•) non-enzymatically and organic hydroperoxides
    catalyzed by GSH peroxidase (GPx) and is thus converted to GSH disulfide (GSSG).
    GSSG is recycled to GSH by GSH reductase (GR), a reaction that uses reduced nicotinamide
    adenine dinucleotide phosphate (NADPH) as a cofactor []. GSH S-transferase (GST)
    forms GSH (GS-R) adducts from organic molecules (R) and GSH, which together with
    GSH and GSSG are exported from the cell by ABC transporters, mainly ABC-1 and
    ABC-G2 [,]. Extracellular GSH is metabolized by the γ-glutamyl transferase (GGT)
    ectoenzyme, which transfers the γ-glutamyl residue to different acceptor amino
    acids, leading to the formation of a dipeptide containing γ-glutamyl and the cysteine
    glycine dipeptide, which is cleaved by extracellular dipeptides to generate cysteine
    and glycine that can be taken up by cells, starting the glutathione biosynthesis
    cycle [].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SRPK
  - gcl
  - Gclc
  - gs
  - gr
  - GstS1
  - GstE12
  - GstD1
  - GstD2
  - GstD3
  - GstD4
  - GstD5
  - GstD6
  - GstD7
  - GstD8
  - TRR-TCT2-1
  - ABCB6
  - GCLC
  - GCA
  - GMCL1
  - GMCL2
  - GPX4
  - GNAS
  - GNAL
  - SLCO6A1
  - GSTK1
  - GSTA1
  - GSTA2
  - GSTA3
  - GSTA4
  - GSTA5
  - GSTM1
  - GSTM2
  - GSTM3
  - GSTM4
  - GSTM5
  - GSTO1
  - GSTO2
  - GSTP1
  - GSTT1
  - GSTT2
  - GSTZ1
  - GSTT2B
  - DECR1
  - SLC7A11
  - SLC3A2
  - GSH
  - Cystine
  - Glutamate
  - Cysteine
  - OOH
  - R-OH
  - H
  - glutamil cisteine
  - Glycine
  - NADP
  - NADPH
  - GS
---
